NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 87 filers reported holding NOVAVAX INC in Q2 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,304,648 | -6.4% | 180,200 | -3.9% | 0.00% | 0.0% |
Q2 2023 | $1,393,868 | +18.7% | 187,600 | +10.7% | 0.00% | 0.0% |
Q1 2023 | $1,174,635 | -39.5% | 169,500 | -10.3% | 0.00% | 0.0% |
Q4 2022 | $1,941,892 | -42.4% | 188,900 | +1.9% | 0.00% | -50.0% |
Q3 2022 | $3,372,000 | -63.5% | 185,300 | +3.1% | 0.00% | -66.7% |
Q2 2022 | $9,247,000 | -59.6% | 179,800 | -42.2% | 0.01% | -53.8% |
Q1 2022 | $22,913,000 | -40.5% | 311,100 | +15.7% | 0.01% | -43.5% |
Q4 2021 | $38,486,000 | -33.3% | 269,000 | -3.4% | 0.02% | -37.8% |
Q3 2021 | $57,736,000 | -4.9% | 278,500 | -2.7% | 0.04% | 0.0% |
Q2 2021 | $60,742,000 | +130.4% | 286,100 | +96.8% | 0.04% | +105.6% |
Q1 2021 | $26,362,000 | +70.7% | 145,400 | +5.0% | 0.02% | +63.6% |
Q4 2020 | $15,444,000 | +8.5% | 138,500 | +5.4% | 0.01% | 0.0% |
Q3 2020 | $14,237,000 | +48.5% | 131,400 | +14.3% | 0.01% | +37.5% |
Q2 2020 | $9,585,000 | +4276.7% | 115,000 | +163.2% | 0.01% | – |
Q3 2019 | $219,000 | -14.5% | 43,688 | 0.0% | 0.00% | – |
Q2 2019 | $256,000 | – | 43,688 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |